{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-23-032140","form_type":"8-K","ticker":"AVTX","cik":"0001534120","company_name":"Avalo Therapeutics, Inc.","filed_at":"2023-09-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:34.228006+00:00","generated_at":"2026-06-10T19:01:27.952847+00:00","sec_items":["3.01","8.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.9,"calibrated_materiality_score":0.9,"confidence":"high","headline":"Avalo Therapeutics faces Nasdaq delisting over low stock price; cash $6.7M","bullets":["Nasdaq notified Avalo of delisting due to bid price ≤ $0.10 for 10 consecutive days (Low Priced Stock Rule).","Company to request hearing by Sept 19; considering reverse stock split to regain compliance.","Preliminary cash and equivalents of ~$6.7M as of Sept 12, 2023.","Raised ~$12.9M net from at-the-market offering (50.8M shares) through Sept 8; additional $1.8M from 16.1M shares after Sept 8.","Shares outstanding: 62,870,563 as of Sept 8, 2023."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-23-032140","json":"https://secwatch.observer/filing/0001628280-23-032140.json","markdown":"https://secwatch.observer/filing/0001628280-23-032140.md","text":"https://secwatch.observer/filing/0001628280-23-032140.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/0001628280-23-032140-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/avtx-20230912.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T19:01:27.952847+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"9155ae9793e924c6ba55aece563729376b3f1a45","claim":"Avalo Therapeutics, Inc. received a nasdaq delisting notice notice regarding minimum bid price (rules 5550(a)(2), 5550(b)(2), 5810(c)(3)(A), 5810(c)(3)(C), 5810(c)(3)(A)(iii)).","evidence_excerpt":"September 12, 2023, the Company received notice (the “September 12 Letter”) from Nasdaq that Nasdaq had determined that as of September 11, 2023, the Company’s securities had a closing bid price of $0.10 or less for ten consecutive trading days triggering application of Listing Rule 5810(c)(3)(A)(iii) which states in part: if during any compliance period specified in Rule 5810(c)(3)(A), a company’s security has a closing bid price of $0.10 or less for ten consecutive trading days, the Listing Qualifications Department shall issue a Staff Delisting Determination under Rule 5810 with respect to","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1534120/000162828023032140/0001628280-23-032140-index.htm","confidence":0.97,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"delisting notice"},{"label":"Deficiency","value":"minimum bid price"},{"label":"Rules","value":"5550(a)(2), 5550(b)(2), 5810(c)(3)(A), 5810(c)(3)(C), 5810(c)(3)(A)(iii)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}